{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:01:22Z","timestamp":1793073682828,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neuropathic pain is a common complication in neuromyelitis optica spectrum disorder (NMOSD), which seriously affects the quality of life of NMOSD patients, with no satisfactory treatment. And risk factors of neuropathic pain are still uncertain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To investigate the risk factors of neuropathic pain in a NMOSD cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>Our study was a retrospective case-cohort study, the patients diagnosed with NMOSD in the Department of Neurology from the Second Affiliated Hospital of Guangzhou University of Chinese Medicine from January 2011 to October 2021 were screened. Inclusion criteria were: (1) patients diagnosed as NMOSD\u00a0according to the International Panel for NMO Diagnosis (IPND) criteria, (2) the aquaporin-4 immunoglobulin G antibodies (AQP4-IgG) test was performed. Patients without AQP4-IgG antibody were excluded. Clinical data, including sex, age of the first onset, symptoms of the first episode including neuropathic pain and attack types, localization of lesions of the first episode on Magnetic Resonance Imaging (MRI), Extended disability status Scale (EDSS) of the first onset, treatment of immunosuppression in the first acute phase, disease modifying therapy (DMT), treatment of neuropathic pain and APQ4-IgG status were collected from the hospital system database. Neuropathic pain was defined according to the International Association for the Study of Pain criteria and was described as \u201cpain arising as a direct consequence of a lesion or disease affecting the somatosensory system\u201d.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One hundred nineteen patients were screened and finally 86 patients fulfilling the inclusion and exclusion criteria were enrolled in our study. The prevalence of neuropathic pain in patients with NMOSD was 43.0%. Univariate analysis showed that the factors associated with neuropathic pain were the age at the onset, the attack type of optic neuritis, the attack type of myelitis, length of spinal cord involvement, localization of thoracic lesion, optic lesion, upper thoracic lesions, lower thoracic lesions, extended spinal cord lesions (\u2265\u20093 spinal lesions), extended thoracic lesions (\u2265\u20094 thoracic lesions), intravenous immunoglobulin and mycophenolate mofetil. Multivariate regression analysis showed that extended thoracic lesions (OR 20.21 [1.18\u2013346.05], <jats:italic>P<\/jats:italic>\u2009=\u20090.038) and age (OR 1.35 (1\u20131.81) <jats:italic>P<\/jats:italic>\u2009=\u20090.050) were independently associated with neuropathic pain among NMOSD patients and that gender (OR 12.11 (0.97\u2013151.64) <jats:italic>P<\/jats:italic>\u2009=\u20090.053) might be associated with neuropathic pain among NMOSD patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Extended thoracic lesions (\u2265\u20094 thoracic lesions), age and gender might be independent risk factors of neuropathic pain among patients with NMOSD. However, with a small sample size and predominantly female, caution must be applied and these results need validating in further cohorts.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02841-9","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T08:03:58Z","timestamp":1660896238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The risk factors of neuropathic pain in neuromyelitis optica spectrum disorder: a retrospective case-cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaojun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyou","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zequan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"2841_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.24554","volume":"79","author":"I Kleiter","year":"2016","unstructured":"Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, Pache F, Ruprecht K, Havla J, Krumbholz M, K\u00fcmpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, NeuromyelitisOptica Study. Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses. Ann Neurol. 2016;79:206\u201316. https:\/\/doi.org\/10.1002\/ana.24554.","journal-title":"Ann Neurol"},{"key":"2841_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","volume":"92","author":"BG Weinshenker","year":"2017","unstructured":"Weinshenker BG, Wingerchuk DM. Neuromyelitis Spectrum Disorders. Mayo Clin Proc. 2017;92:663\u201379. https:\/\/doi.org\/10.1016\/j.mayocp.2016.12.014.","journal-title":"Mayo Clin Proc"},{"key":"2841_CR3","doi-asserted-by":"publisher","first-page":"e985","DOI":"10.1212\/NXI.0000000000000985","volume":"8","author":"I Ayzenberg","year":"2021","unstructured":"Ayzenberg I, Richter D, Henke E, Asseyer S, Paul F, Trebst C, H\u00fcmmert MW, Havla J, K\u00fcmpfel T, Ringelstein M, Aktas O, Wildemann B, Jarius S, H\u00e4u\u00dfler V, Stellmann J-P, Senel M, Klotz L, Pellkofer HL, Weber MS, Pawlitzki M, Rommer PS, Berthele A, Wernecke K-D, Hellwig K, Gold R, Kleiter I. on behalf of the NEMOS (Neuromyelitis Optica Study Group), Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients. Neurol - Neuroimmunol Neuroinflammation. 2021;8:e985. https:\/\/doi.org\/10.1212\/NXI.0000000000000985.","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"2841_CR4","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1001\/archneurol.2012.768","volume":"69","author":"P Qian","year":"2012","unstructured":"Qian P, Lancia S, Alvarez E, Klawiter EC, Cross AH, Naismith RT. Association of neuromyelitis optica with severe and intractable pain. Arch Neurol. 2012;69:1482. https:\/\/doi.org\/10.1001\/archneurol.2012.768.","journal-title":"Arch Neurol"},{"key":"2841_CR5","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1212\/WNL.0b013e318229e694","volume":"77","author":"Y Kanamori","year":"2011","unstructured":"Kanamori Y, Nakashima I, Takai Y, Nishiyama S, Kuroda H, Takahashi T, Kanaoka-Suzuki C, Misu T, Fujihara K, Itoyama Y. Pain in neuromyelitis optica and its effect on quality of life: a cross-sectional study. Neurology. 2011;77:652\u20138. https:\/\/doi.org\/10.1212\/WNL.0b013e318229e694.","journal-title":"Neurology"},{"key":"2841_CR6","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1177\/1352458514522103","volume":"20","author":"S Zhao","year":"2014","unstructured":"Zhao S, Mutch K, Elsone L, Nurmikko T, Jacob A. Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life. Mult Scler J. 2014;20:1658\u201361. https:\/\/doi.org\/10.1177\/1352458514522103.","journal-title":"Mult Scler J"},{"key":"2841_CR7","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.3390\/jcm9113604","volume":"9","author":"M Barzegar","year":"2020","unstructured":"Barzegar M, SadeghiBahmani D, Mirmosayyeb O, Azarbayejani R, Afshari-Safavi A, Vaheb S, Nehzat N, Dana A, Shaygannejad V, Motl RW, Brand S. Higher disease and pain severity and fatigue and lower balance skills are associated with higher prevalence of falling among individuals with the inflammatory disease of Neuromyelitis Optica Spectrum Disorder (NMOSD). J Clin Med. 2020;9:3604. https:\/\/doi.org\/10.3390\/jcm9113604.","journal-title":"J Clin Med"},{"key":"2841_CR8","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1212\/NXI.0000000000000580","volume":"6","author":"J Beekman","year":"2019","unstructured":"Beekman J, Keisler A, Pedraza O, Haramura M, Gianella-Borradori A, Katz E, Ratchford JN, Barron G, Cook LJ, Behne JM, Blaschke TF, Smith TJ, Yeaman MR. Neuromyelitis optica spectrum disorder: Patient experience and quality of life. Neurol - Neuroimmunol Neuroinflammation. 2019;6:e580. https:\/\/doi.org\/10.1212\/NXI.0000000000000580.","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"2841_CR9","doi-asserted-by":"publisher","first-page":"102542","DOI":"10.1016\/j.msard.2020.102542","volume":"46","author":"W Huang","year":"2020","unstructured":"Huang W, ZhangBao J, Chang X, Wang L, Zhao C, Lu J, Wang M, Ding X, Xu Y, Zhou L, Li D, Behne MK, Behne JM, Yeaman MR, Katz E, Lu C, Quan C. Neuromyelitis optica spectrum disorder in China: quality of life and medical care experience. Mult Scler Relat Disord. 2020;46:102542. https:\/\/doi.org\/10.1016\/j.msard.2020.102542.","journal-title":"Mult Scler Relat Disord"},{"key":"2841_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.7224\/1537-2073.2017-076","volume":"21","author":"MA Mealy","year":"2019","unstructured":"Mealy MA, Boscoe A, Caro J, Levy M. Assessment of Patients with Neuromyelitis Optica Spectrum Disorder Using the EQ-5D. Int J MS Care. 2019;21:129\u201334. https:\/\/doi.org\/10.7224\/1537-2073.2017-076.","journal-title":"Int J MS Care"},{"key":"2841_CR11","doi-asserted-by":"publisher","first-page":"205521731879668","DOI":"10.1177\/2055217318796684","volume":"4","author":"S Asseyer","year":"2018","unstructured":"Asseyer S, Schmidt F, Chien C, Scheel M, Ruprecht K, Bellmann-Strobl J, Brandt AU, Paul F. 4Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders. Mult Scler J - Exp Transl Clin. 2018;4:205521731879668. https:\/\/doi.org\/10.1177\/2055217318796684.","journal-title":"Mult Scler J - Exp Transl Clin"},{"key":"2841_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1136\/jnnp-2016-314991","volume":"88","author":"G Tackley","year":"2017","unstructured":"Tackley G, Vecchio D, Hamid S, Jurynczyk M, Kong Y, Gore R, Mutch K, Woodhall M, Waters P, Vincent A, Leite MI, Tracey I, Jacob A, Palace J. Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis. J Neurol Neurosurg Psychiatry. 2017;88:165\u20139. https:\/\/doi.org\/10.1136\/jnnp-2016-314991.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2841_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jns.2016.06.041","volume":"368","author":"Y Kong","year":"2016","unstructured":"Kong Y, Okoruwa H, Revis J, Tackley G, Leite MI, Lee M, Tracey I, Palace J. Pain in patients with transverse myelitis and its relationship to aquaporin 4 antibody status. J Neurol Sci. 2016;368:84\u20138. https:\/\/doi.org\/10.1016\/j.jns.2016.06.041.","journal-title":"J Neurol Sci"},{"key":"2841_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177\u201389. https:\/\/doi.org\/10.1212\/WNL.0000000000001729.","journal-title":"Neurology"},{"key":"2841_CR15","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","volume":"87","author":"P Waters","year":"2016","unstructured":"Waters P, Reindl M, Saiz A, Schanda K, Tuller F, Kral V, Nytrova P, Sobek O, Nielsen HH, Barington T, Lillevang ST, Illes Z, Rentzsch K, Berthele A, Berki T, Granieri L, Bertolotto A, Giometto B, Zuliani L, Hamann D, van Pelt ED, Hintzen R, H\u00f6ftberger R, Costa C, Comabella M, Montalban X, Tintor\u00e9 M, Siva A, Altintas A, Deniz G, Woodhall M, Palace J, Paul F, Hartung H-P, Aktas O, Jarius S, Wildemann B, Vedeler C, Ruiz A, Leite MI, Trillenberg P, Probst M, Saschenbrecker S, Vincent A, Marignier R. Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. J Neurol Neurosurg Psychiatry. 2016;87:1005\u201315. https:\/\/doi.org\/10.1136\/jnnp-2015-312601.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2841_CR16","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","volume":"70","author":"R-D Treede","year":"2008","unstructured":"Treede R-D, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630\u20135. https:\/\/doi.org\/10.1212\/01.wnl.0000282763.29778.59.","journal-title":"Neurology"},{"key":"2841_CR17","doi-asserted-by":"publisher","first-page":"101432","DOI":"10.1016\/j.msard.2019.101432","volume":"37","author":"T Wang","year":"2020","unstructured":"Wang T, Lian Z, Wu X, Kong Y, Zhou H, Wei M. Subcortical structural abnormalities in female neuromyelitis optica patients with neuropathic pain. Mult Scler Relat Disord. 2020;37:101432. https:\/\/doi.org\/10.1016\/j.msard.2019.101432.","journal-title":"Mult Scler Relat Disord"},{"key":"2841_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/acn3.85","volume":"1","author":"DT Okuda","year":"2014","unstructured":"Okuda DT, Melmed K, Matsuwaki T, Blomqvist A, Craig ADB. Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions. Ann Clin Transl Neurol. 2014;1:554\u201361. https:\/\/doi.org\/10.1002\/acn3.85.","journal-title":"Ann Clin Transl Neurol"},{"key":"2841_CR19","doi-asserted-by":"publisher","first-page":"e0224419","DOI":"10.1371\/journal.pone.0224419","volume":"15","author":"H Masuda","year":"2020","unstructured":"Masuda H, Mori M, Uzawa A, Uchida T, Ohtani R, Kuwabara S. Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis. PLoS One. 2020;15:e0224419. https:\/\/doi.org\/10.1371\/journal.pone.0224419.","journal-title":"PLoS One"},{"key":"2841_CR20","doi-asserted-by":"publisher","first-page":"102579","DOI":"10.1016\/j.msard.2020.102579","volume":"46","author":"S Asseyer","year":"2020","unstructured":"Asseyer S, Kuchling J, Gaetano L, Komneni\u0107 D, Siebert N, Chien C, Scheel M, Oertel FC, Ruprecht K, Bellmann-Strobl J, Finke C, Chakravarty MM, Magon S, Wuerfel J, Paul F, Papadopoulou A, Brandt AU. Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders. Mult Scler Relat Disord. 2020;46:102579. https:\/\/doi.org\/10.1016\/j.msard.2020.102579.","journal-title":"Mult Scler Relat Disord"},{"key":"2841_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/ijms19010281","volume":"19","author":"V Coraggio","year":"2018","unstructured":"Coraggio V, Guida F, Boccella S, Scafuro M, Paino S, Romano D, Maione S, Luongo L. Neuroimmune-driven neuropathic pain establishment: a focus on gender differences. Int J Mol Sci. 2018;19:281. https:\/\/doi.org\/10.3390\/ijms19010281.","journal-title":"Int J Mol Sci"},{"key":"2841_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1124\/jpet.120.265017","volume":"375","author":"K Halievski","year":"2020","unstructured":"Halievski K, Ghazisaeidi S, Salter MW. Sex-dependent mechanisms of chronic pain: a focus on microglia and P2X4R. J Pharmacol Exp Ther. 2020;375:202\u20139. https:\/\/doi.org\/10.1124\/jpet.120.265017.","journal-title":"J Pharmacol Exp Ther"},{"key":"2841_CR23","doi-asserted-by":"publisher","unstructured":"Machelska H, Celik M\u00d6. Recent advances in understanding neuropathic pain: glia, sex differences, and epigenetics, 2016. https:\/\/doi.org\/10.12688\/f1000research.9621.1.","DOI":"10.12688\/f1000research.9621.1"},{"key":"2841_CR24","doi-asserted-by":"publisher","first-page":"15450","DOI":"10.1523\/JNEUROSCI.3859-11.2011","volume":"31","author":"RE Sorge","year":"2011","unstructured":"Sorge RE, LaCroix-Fralish ML, Tuttle AH, Sotocinal SG, Austin J-S, Ritchie J, Chanda ML, Graham AC, Topham L, Beggs S, Salter MW, Mogil JS. Spinal cord toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice. J Neurosci. 2011;31:15450\u20134. https:\/\/doi.org\/10.1523\/JNEUROSCI.3859-11.2011.","journal-title":"J Neurosci"},{"key":"2841_CR25","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nn.4053","volume":"18","author":"RE Sorge","year":"2015","unstructured":"Sorge RE, Mapplebeck JCS, Rosen S, Beggs S, Taves S, Alexander JK, Martin LJ, Austin J-S, Sotocinal SG, Chen D, Yang M, Shi XQ, Huang H, Pillon NJ, Bilan PJ, Tu YS, Klip A, Ji R-R, Zhang J, Salter MW, Mogil JS. Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nat Neurosci. 2015;18:1081\u20133. https:\/\/doi.org\/10.1038\/nn.4053.","journal-title":"Nat Neurosci"},{"key":"2841_CR26","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.12688\/f1000research.9621.1","volume":"5","author":"H Machelska","year":"2016","unstructured":"Machelska H, Celik M\u00d6. Recent advances in understanding neuropathic pain: glia, sex differences, and epigenetics. F1000Res. 2016;5:2743. https:\/\/doi.org\/10.12688\/f1000research.9621.1.","journal-title":"F1000Res"},{"key":"2841_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.expneurol.2015.07.013","volume":"275","author":"M Fitzgerald","year":"2016","unstructured":"Fitzgerald M, McKelvey R. Nerve injury and neuropathic pain \u2014 A question of age. Exp Neurol. 2016;275:296\u2013302. https:\/\/doi.org\/10.1016\/j.expneurol.2015.07.013.","journal-title":"Exp Neurol"},{"key":"2841_CR28","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1111\/odi.12145","volume":"20","author":"L da Silva","year":"2014","unstructured":"da Silva L, Lin S, Teixeira M, de Siqueira J, Jacob Filho W, de Siqueira S. Sensorial differences according to sex and ages. Oral Dis. 2014;20:e103\u201310. https:\/\/doi.org\/10.1111\/odi.12145.","journal-title":"Oral Dis"},{"key":"2841_CR29","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1084\/jem.20081241","volume":"205","author":"SR Hinson","year":"2008","unstructured":"Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, Howe CL, Pittock SJ, Lennon VA. Aquaporin-4\u2013binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med. 2008;205:2473\u201381. https:\/\/doi.org\/10.1084\/jem.20081241.","journal-title":"J Exp Med"},{"key":"2841_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1017\/S1740925X11000093","volume":"6","author":"J Albrecht","year":"2010","unstructured":"Albrecht J, Sidoryk-W\u0119grzynowicz M, Zieli\u0144ska M, Aschner M. Roles of glutamine in neurotransmission. Neuron Glia Biol. 2010;6:263\u201376. https:\/\/doi.org\/10.1017\/S1740925X11000093.","journal-title":"Neuron Glia Biol"},{"key":"2841_CR31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrneurol.2014.129","volume":"10","author":"M Bradl","year":"2014","unstructured":"Bradl M, Kanamori Y, Nakashima I, Misu T, Fujihara K, Lassmann H, Sandk\u00fchler J. Pain in neuromyelitis optica\u2014prevalence, pathogenesis and therapy. Nat Rev Neurol. 2014;10:529\u201336. https:\/\/doi.org\/10.1038\/nrneurol.2014.129.","journal-title":"Nat Rev Neurol"},{"key":"2841_CR32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12974-019-1524-2","volume":"16","author":"T Li","year":"2019","unstructured":"Li T, Chen X, Zhang C, Zhang Y, Yao W. An update on reactive astrocytes in chronic pain. J Neuroinflammation. 2019;16:140. https:\/\/doi.org\/10.1186\/s12974-019-1524-2.","journal-title":"J Neuroinflammation"},{"key":"2841_CR33","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41583-019-0218-1","volume":"20","author":"RR Ji","year":"2019","unstructured":"Ji RR, Donnelly CR, Nedergaard M. Astrocytes in chronic pain and itch. Nat Rev Neurosci. 2019;20:667\u201385. https:\/\/doi.org\/10.1038\/s41583-019-0218-1.","journal-title":"Nat Rev Neurosci"},{"key":"2841_CR34","doi-asserted-by":"publisher","first-page":"102408","DOI":"10.1016\/j.msard.2020.102408","volume":"45","author":"Q Li","year":"2020","unstructured":"Li Q, Wang B, Yang J, Zhou L, Bao JZ, Wang L, Zhang A, Liu C, Quan C, Li F. Painful tonic spasm in Chinese patients with neuromyelitis optica spectrum disorder: Prevalence, subtype, and features. Mult Scler Relat Disord. 2020;45:102408. https:\/\/doi.org\/10.1016\/j.msard.2020.102408.","journal-title":"Mult Scler Relat Disord"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02841-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02841-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02841-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T08:06:22Z","timestamp":1660896382000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02841-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2841"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02841-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"assertion":[{"value":"23 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Ethics Committee of the Second Affiliated Hospital of Guangzhou University of Chinese Medicine (No.YE2021-308) and conducted on the basis of the Declaration of Helsinki. According to ethic guidelines, the requirement of informed consent was waived since this study had no potential to harm the rights or welfare of subjects. And the Ethics Committee of the Second Affiliated Hospital of Guangzhou University of Chinese Medicine approved the waiver of informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}